We desperately need clean long-term safety data on the mRNA shots by Alex Berenson for UnReported Truths
Here’s how we get it
The red flags about mRNA shots are everywhere.
Cellular-level research shows the artificial mRNA in the jabs lingers in the body for months. Side effect data show they are linked to far more problems than other vaccines. Most importantly, deaths from all causes remain high in countries that used the shots.
Now is your chance to support Gospel News Network.
We love helping others and believe that’s one of the reasons we are chosen as Ambassadors of the Kingdom, to serve God’s children. We look to the Greatest Commandment as our Powering force.
But we do not have the most crucial evidence – long-term safety data from large, randomized, blinded, placebo-controlled clinical trials. Those trials compare two groups of evenly matched people who receive either a vaccine or a placebo shot. They are not perfect. But they are the cornerstone of modern medicine, the strongest evidence available for (or against) any therapeutic.
Pfizer and Moderna, the mRNA vaccine companies, ran those trials in 2020, including about 70,000 people. Then the companies ruined them. With regulatory approval, in early 2021 Pfizer and Moderna gave people who had received placebo shots in the trial the option to take the vaccines instead. In doing so, they destroyed any chance for long-term safety data.
We need that data.
We need a do-over.
—
And the companies have given us a chance for one, if only regulators will take it.
How?
After all, no one is running large clinical trials of mRNA Covid vaccines right now. Not when regulators will authorize boosters based on a handful of mice. And not with demand for Covid boosters falling faster than China’s commitment to human rights.
(Actual Centers for Disease Control report on current mRNA vaccine demand)
—
But Pfizer and Moderna have not given up on the mRNA dream. (I’ll avoid calling it a grift; I am sick to death of that word.)
And so both companies have started large pivotal trials for mRNA vaccines for influenza. Pfizer’s includes 25,000 people, and Moderna’s 23,000.
